PTPN13 and malignant colon neoplasm: In consistence with our in vivo evaluation, our data demonstrated a dose-dependent increase in the amount of apoptosis induced by CH-11 in colon cancer cells in parallel to a reduced expression of FAP-1 mRNA and protein.